Cargando…

Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions

BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid h...

Descripción completa

Detalles Bibliográficos
Autores principales: Bariya, Deepak, Mishra, Shashi Prakash, Akshay, BR, Kumari, Sweety, Akanksha, Khanna, Rahul, Meena, Ram Niwas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480793/
https://www.ncbi.nlm.nih.gov/pubmed/36119205
http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21
_version_ 1784791119764127744
author Bariya, Deepak
Mishra, Shashi Prakash
Akshay, BR
Kumari, Sweety
Akanksha,
Khanna, Rahul
Meena, Ram Niwas
author_facet Bariya, Deepak
Mishra, Shashi Prakash
Akshay, BR
Kumari, Sweety
Akanksha,
Khanna, Rahul
Meena, Ram Niwas
author_sort Bariya, Deepak
collection PubMed
description BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid hormone, yet few researches have been done on its relationship with VEGF. AIM: To study the clinical and demographic profile of thyroid lesions (benign and malignant) and to explored the relationship between VEGF expression (using immunochemistry) and serum TSH level. METHODS: This prospective, observational study includes 61 patients of thyroid lesions who underwent partial, hemi, subtotal or total thyroidectomy as the primary treatment from June 2014 and July 2016. Tissue specimens of thyroid lesions for immunohistochemistry study of VEGF expression were done. Serum TSH was done using Chemiluminiscence technique and correlated to VEGF expression. RESULTS: The mean age of patient was 36.26 ± 11.53 years (range 20-50 years) with female preponderance. Swelling was the most common presenting symptom. Of 61 patients, 37 (60.65%) patients were benign and 24 (39.35%) were malignant thyroid lesions. The mean TSH level in benign group was 1.92 ± 0.94 mIU/liter and malignant group was 2.73 ± 1.74 mIU/liter which was statistically significant (P = 0.023). VEGF expression was strongly positive (3+) in 26 (42.62%) patients and negative/equivocal (1+ & 2+) in 35 (57.38%) patients. In benign group, 10 (27.0%) patients were strongly positive for VEGF whereas in malignant group, 16 (66.7%) patients were strongly positive for VEGF showed significant association (P = 0.002). On comparing TSH level of benign, malignant and total patients separately with VEGF expression, significant association were also observed (P < 0.001, P = 0.004 and P < 0.001, respectively). CONCLUSION: VEGF was strongly expressed in malignant thyroid lesions which are having high serum concentration of serum TSH level. Serum TSH levels reveal a significant correlation with VEGF expression.
format Online
Article
Text
id pubmed-9480793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-94807932022-09-17 Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions Bariya, Deepak Mishra, Shashi Prakash Akshay, BR Kumari, Sweety Akanksha, Khanna, Rahul Meena, Ram Niwas J Family Med Prim Care Original Article BACKGROUND: Vascular endothelial growth factor (VEGF) stimulates angiogenesis, increases vascular permeability and seems to correlate to aggressiveness of tumors. Thyroid cancer has been found to have higher levels of VEGF expression. Thyroid stimulating hormone (TSH) is the most important thyroid hormone, yet few researches have been done on its relationship with VEGF. AIM: To study the clinical and demographic profile of thyroid lesions (benign and malignant) and to explored the relationship between VEGF expression (using immunochemistry) and serum TSH level. METHODS: This prospective, observational study includes 61 patients of thyroid lesions who underwent partial, hemi, subtotal or total thyroidectomy as the primary treatment from June 2014 and July 2016. Tissue specimens of thyroid lesions for immunohistochemistry study of VEGF expression were done. Serum TSH was done using Chemiluminiscence technique and correlated to VEGF expression. RESULTS: The mean age of patient was 36.26 ± 11.53 years (range 20-50 years) with female preponderance. Swelling was the most common presenting symptom. Of 61 patients, 37 (60.65%) patients were benign and 24 (39.35%) were malignant thyroid lesions. The mean TSH level in benign group was 1.92 ± 0.94 mIU/liter and malignant group was 2.73 ± 1.74 mIU/liter which was statistically significant (P = 0.023). VEGF expression was strongly positive (3+) in 26 (42.62%) patients and negative/equivocal (1+ & 2+) in 35 (57.38%) patients. In benign group, 10 (27.0%) patients were strongly positive for VEGF whereas in malignant group, 16 (66.7%) patients were strongly positive for VEGF showed significant association (P = 0.002). On comparing TSH level of benign, malignant and total patients separately with VEGF expression, significant association were also observed (P < 0.001, P = 0.004 and P < 0.001, respectively). CONCLUSION: VEGF was strongly expressed in malignant thyroid lesions which are having high serum concentration of serum TSH level. Serum TSH levels reveal a significant correlation with VEGF expression. Wolters Kluwer - Medknow 2022-06 2022-06-30 /pmc/articles/PMC9480793/ /pubmed/36119205 http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Bariya, Deepak
Mishra, Shashi Prakash
Akshay, BR
Kumari, Sweety
Akanksha,
Khanna, Rahul
Meena, Ram Niwas
Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title_full Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title_fullStr Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title_full_unstemmed Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title_short Relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
title_sort relationship between vascular endothelial growth factor expression and thyroid stimulating hormone level in benign and malignant thyroid lesions
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480793/
https://www.ncbi.nlm.nih.gov/pubmed/36119205
http://dx.doi.org/10.4103/jfmpc.jfmpc_1126_21
work_keys_str_mv AT bariyadeepak relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT mishrashashiprakash relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT akshaybr relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT kumarisweety relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT akanksha relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT khannarahul relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions
AT meenaramniwas relationshipbetweenvascularendothelialgrowthfactorexpressionandthyroidstimulatinghormonelevelinbenignandmalignantthyroidlesions